Editas Medicine, Inc.
SYSTEMS AND METHODS FOR TREATING ALPHA 1-ANTITRYPSIN (A1AT) DEFICIENCY
Last updated:
Abstract:
CRISPR/RNA-guided nuclease-related compositions and methods for treatment of A1AT deficiency and associated conditions are disclosed.
Status:
Application
Type:
Utility
Filling date:
24 Mar 2017
Issue date:
9 Jul 2020